<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>米内网 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-20T20:18:27+08:00</updated>
  <subtitle>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>2020全国信息会最新议程来了！政策解读、经济预测、大咖互动……报名通道开启</title>
    <updated>2020-11-20T19:31:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/RggDN9hn1GL9x9VqCZpZ9g</id>
    <link href="https://mp.weixin.qq.com/s/RggDN9hn1GL9x9VqCZpZ9g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【10周年献礼】珍宝岛：结缘于战略规划，因为有米内这样的合作伙伴而感到幸福</title>
    <updated>2020-11-20T19:31:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/8vH67rtS6mF0kHdIGNDdFg</id>
    <link href="https://mp.weixin.qq.com/s/8vH67rtS6mF0kHdIGNDdFg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】输液龙头拿下20亿大品种过评！科伦28个注射剂冲击首家过评</title>
    <updated>2020-11-20T19:31:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/tPJYcH8nOWCpGIl-STN5Gg</id>
    <link href="https://mp.weixin.qq.com/s/tPJYcH8nOWCpGIl-STN5Gg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【焦点】人福发威了！这个精神兴奋药首家过评定了</title>
    <updated>2020-11-20T19:31:11+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-20:/s/Cevge4p6sLQfCbxVqi8MfA</id>
    <link href="https://mp.weixin.qq.com/s/Cevge4p6sLQfCbxVqi8MfA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【10周年献礼】华东医药：以市场表现和临床评价为锚点，为产品引进提供数据支持</title>
    <updated>2020-11-19T17:02:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/qf6zoQ9qkQ3TqNDTlVzr-A</id>
    <link href="https://mp.weixin.qq.com/s/qf6zoQ9qkQ3TqNDTlVzr-A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】50亿抗菌药扬子江首家过评，80亿大品种拿下独家剂型</title>
    <updated>2020-11-19T17:02:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/1ZbRvNcJKBDVRjhPtcvfwQ</id>
    <link href="https://mp.weixin.qq.com/s/1ZbRvNcJKBDVRjhPtcvfwQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【审评】豪森、正大天晴、华海“抢食”抗高血压药！山东药企入局</title>
    <updated>2020-11-19T17:02:34+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-19:/s/8_z-a447_29pBH5sN1JSCQ</id>
    <link href="https://mp.weixin.qq.com/s/8_z-a447_29pBH5sN1JSCQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>最新！呼吸系统中成药TOP20出炉，3个超10亿品牌抢眼，华润领军，康缘1类新药来了</title>
    <updated>2020-11-18T15:59:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/uzjvfxqCsvQRluwO793vAQ</id>
    <link href="https://mp.weixin.qq.com/s/uzjvfxqCsvQRluwO793vAQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【10周年献礼】天士力：依托米内数据库，洞悉中药注射剂的未来发展趋势</title>
    <updated>2020-11-18T15:59:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/6a04Qpe3mjKc1A9lAxAk3A</id>
    <link href="https://mp.weixin.qq.com/s/6a04Qpe3mjKc1A9lAxAk3A" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】东阳光药拿下15亿大品种，24个新品在路上</title>
    <updated>2020-11-18T15:59:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/NFVDTYcbH_rgDNoGGtpSsw</id>
    <link href="https://mp.weixin.qq.com/s/NFVDTYcbH_rgDNoGGtpSsw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】2款超20亿注射剂，科伦、豪森首家过评</title>
    <updated>2020-11-18T15:59:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-18:/s/lsPE7WpprQ94Rw8wMlNVhg</id>
    <link href="https://mp.weixin.qq.com/s/lsPE7WpprQ94Rw8wMlNVhg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>20个中成药厉害了！华润、太极、扬子江……9个独家中成药亮眼，60亿大品种领跑</title>
    <updated>2020-11-17T15:57:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/qyebfc7V77mE9Rwl7RM2Aw</id>
    <link href="https://mp.weixin.qq.com/s/qyebfc7V77mE9Rwl7RM2Aw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【10周年献礼】复旦张江：从仿制药立项到销售策略抉择，十载同行，共同见证</title>
    <updated>2020-11-17T15:57:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/zbp3eup4kwB2JXE4rbJFDw</id>
    <link href="https://mp.weixin.qq.com/s/zbp3eup4kwB2JXE4rbJFDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】60亿PPI注射剂！华东医药过评了</title>
    <updated>2020-11-17T15:57:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/fv3jG1DxgxlapR9OZQosPw</id>
    <link href="https://mp.weixin.qq.com/s/fv3jG1DxgxlapR9OZQosPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【市场】四川药企将拿下$120亿明星抗凝药</title>
    <updated>2020-11-17T15:57:32+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-17:/s/mhgGcUpHLPWdq0srtL2ctA</id>
    <link href="https://mp.weixin.qq.com/s/mhgGcUpHLPWdq0srtL2ctA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>80亿监控品种遭“腰斩”，扬子江独揽两个10亿品牌！新药、首仿“点亮”千亿市场</title>
    <updated>2020-11-16T15:54:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/mA0Q45DGkT42weXeai92mA</id>
    <link href="https://mp.weixin.qq.com/s/mA0Q45DGkT42weXeai92mA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【10周年献礼】金花股份：精准研判行业发展，引导终端渠道走向，米内伴我前行</title>
    <updated>2020-11-16T15:54:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/RdBkMXMBMZtWM2ncwJGWcQ</id>
    <link href="https://mp.weixin.qq.com/s/RdBkMXMBMZtWM2ncwJGWcQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【重磅】华东将拿下$20亿口服降糖药，与东阳光药围攻默沙东</title>
    <updated>2020-11-16T15:54:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/1dF8Z5mFhR18yLwob4M5Ig</id>
    <link href="https://mp.weixin.qq.com/s/1dF8Z5mFhR18yLwob4M5Ig" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【瞩目】四川药企冲击20亿大品种首家过评，仅1家已获国产批文</title>
    <updated>2020-11-16T15:54:35+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-16:/s/MjAX3RhoyxzWJ96yFyRNmg</id>
    <link href="https://mp.weixin.qq.com/s/MjAX3RhoyxzWJ96yFyRNmg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>“研发一哥”名不虚传！49个1类新药亮眼，12个首仿胜券在握，进攻慢病药、高端制剂</title>
    <updated>2020-11-15T07:53:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-15:/s/a2YzanxrYrXoPrEnMk-HIA</id>
    <link href="https://mp.weixin.qq.com/s/a2YzanxrYrXoPrEnMk-HIA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>